Staphylococcus Aureus Infections
📧 Sign up to get email alerts when something new happens for Staphylococcus Aureus Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant [Phase 1]
Phase 1 feasibility and safety study evaluating parent-to-child nasal microbiota transplant to address Staphylococcus aureus colonization an…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome [Phase 1]
Phase 1 clinical trial assessing single versus repeat nasal microbiome transplant (NMT) in neonates, examining effects on Staphylococcus aur…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection [Phase 2]
Phase 2 clinical trial update evaluating target attainment of continuous infusion flucloxacillin and cefazolin with therapeutic drug monitor…
-
FDA approval · 2022-12-06FDA Approved: NAFCILLIN — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for NAFCILLIN SODIUM (NAFCILLIN) from Heritage Pharmaceuticals Inc. (Avet Pharmaceuticals Inc.).
-
FDA approval · 2022-11-14FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)
FDA approved the original application for vancomycin hydrochloride (generic) by Ascend Laboratories, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of Staphylococcus [Phase 1, Phase 2]
A clinical trial evaluating the safety and efficacy of 3% LTX-109 for nasal decolonization of Staphylococcus aureus has completed Phase 1 an…
-
CLINICAL_TRIALS research · 2018-06-12Clinical Trial Update: Risk Factors for Linezolid Resistance in Staphylococcus Aureus
Clinical trial update examining risk factors for linezolid resistance in Staphylococcus aureus; the study has completed.
-
FDA approval · 2018-02-21FDA Approved: VANCOMYCIN HYDROCHLORIDE — Supplemental Application (SAMSON MEDICAL TECHNOLOGIES LLC)
The FDA approved Samson Medical Technologies LLC's supplemental application for vancomycin hydrochloride, a generic antibiotic, under an app…
-
FDA approval · 2017-07-14FDA Approved: NAFCILLIN — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for naficillin submitted by Baxter Healthcare Corporation.
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE) [Phase 2]
Phase 2 pilot trial evaluating whether Lactobacillus rhamnosus can reduce colonization by MRSA; the study is completed.
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus. [Phase 3]
Phase 3 trial evaluating short-term sequential therapy for non-complicated catheter-related bloodstream infection due to methicillin-suscept…
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis
A completed clinical trial evaluating Staphylococcus aureus carrier status in breastfeeding mothers and infants and its relation to lactatio…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years [Phase 1]
A Phase 1 trial assessed a single vaccination with the four-antigen Staphylococcus aureus vaccine SA4Ag in healthy adults aged 18 to under 6…
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Volatile Organic Compounds in Staphylococcus Aureus Patients
A completed clinical trial evaluating volatile organic compounds in patients with Staphylococcus aureus infections, including MRSA and nosoc…
-
FDA approval · 2012-12-26FDA Approved: NAFCILLIN — Original Application (Eugia US LLC)
FDA approves Nafcillin sodium as an original application generic drug for Eugia US LLC (ANDA 091613).
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: Vitamin D and Staphylococcus Aureus in the Diabetes Study [Phase 3]
Phase 3 trial update examining whether vitamin D influences Staphylococcus aureus infections in people with diabetes; the study has complete…
-
CLINICAL_TRIALS trial_result · 2012-03-21Clinical Trial Update: Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections [NA]
This cost-effectiveness clinical trial compared chlorhexidine bathing with active surveillance cultures versus active surveillance alone for…
-
CLINICAL_TRIALS trial_result · 2011-10-17Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002) [Phase 1]
This Phase 1 trial evaluated safety, tolerability, and immunogenicity of a single dose of Merck's V710 Staphylococcus aureus vaccine, given …
-
FDA approval · 2011-10-03FDA Approved: NAFCILLIN — Original Application (Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc.)
The FDA approved Nafcillin sodium as a generic drug via an original ANDA from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals Inc.). It…
-
FDA approval · 2011-04-20FDA Approved: NAFCILLIN — Original Application (Athenex Pharmaceutical Division, LLC.)
FDA approves the original application for Nafcillin (nafcillin sodium) as a generic antibiotic from Athenex Pharmaceutical Division, LLC.
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center?
This completed clinical trial reports the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in skin and soft tissue infection…
-
CLINICAL_TRIALS trial_result · 2010-10-20Clinical Trial Update: V710 First-In-Man (FIM) Study (V710-001) [Phase 1]
Merck's V710 first-in-man Phase 1 study for preventing Staphylococcus aureus infections has completed, with results posted in October 2010.
-
CLINICAL_TRIALS trial_result · 2010-08-20Clinical Trial Update: Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus [Phase 2]
Phase 2 clinical trial evaluating retapamulin ointment for nasal decolonization of Staphylococcus aureus in healthy adults; results have bee…
-
FDA approval · 2010-04-27FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Plano Pharmaceuticals Inc.)
FDA approved Plano Pharmaceuticals Inc.'s original ANDA for vancomycin hydrochloride, granting generic approval for this injectable antibiot…
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections [Phase 2]
Phase 2 safety and efficacy study of a fluoroquinolone for complicated skin infections completed; results posted.